EMD SERONO
LIVE

Serial Number

88220392

Owner

MERCK KGAA

Attorney

William C. Wright

First Use Date

Oct 31, 2007

Filing Date

Dec 6, 2018

Add to watchlist:

No watchlists yet
View on USPTO

EMD SERONO Trademark

Serial Number: 88220392 • Registration: 6285603

EMD SERONO is a trademark filed by MERCK KGAA on December 6, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

MERCK KGAA (1,594 trademarks)

DARMSTADT 64293 , DE

Entity Type: 31

Trademark Details

Filing Date

December 6, 2018

Registration Date

March 9, 2021

First Use Anywhere

October 31, 2007

First Use in Commerce

October 31, 2007

Published for Opposition

December 22, 2020

Goods & Services

Medical apparatus, instruments and equipment, namely, incubators and parts and fittings specially designed therefore used to support development of human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes for in vitro fertilization or treatment of infertility and other disorders relating to fertility and human reproduction; injection devices for pharmaceuticals

Printed instructional and teaching material in the field of healthcare

Providing medical information, consultancy and advisory services

Downloadable software in the nature of a mobile application that enables users to access healthcare information

Conducting business conferences in the healthcare area

Providing training about the administration of drugs; conducting educational conferences in the healthcare area

Pharmaceutical preparations for the treatment of diseases and disorders of neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology; prefilled syringes containing choriogonadotropin alfa, prefilled syringes containing follitropin alfa, prefilled syringes containing interferon beta-1a, prefilled syringes containing cetrorelix

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 9, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 9, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 22, 2020 NPUB
PUBLISHED FOR OPPOSITION
Dec 22, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 2, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 19, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 17, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 17, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 17, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 17, 2020 CNEA
EXAMINER'S AMENDMENT ENTERED
Oct 28, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 28, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 28, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 28, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 19, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 19, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 19, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 23, 2020 GNRN
NON-FINAL ACTION E-MAILED
Apr 23, 2020 GNRT
NON-FINAL ACTION WRITTEN
Apr 23, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 9, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 9, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 10, 2019 GNRN
NON-FINAL ACTION E-MAILED
Oct 10, 2019 GNRT
NON-FINAL ACTION WRITTEN
Oct 10, 2019 CNRT
ASSIGNED TO EXAMINER
Oct 1, 2019 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 20, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 20, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 20, 2019 GNRN
NON-FINAL ACTION E-MAILED
Feb 20, 2019 GNRT
NON-FINAL ACTION WRITTEN
Feb 20, 2019 CNRT
ASSIGNED TO EXAMINER
Feb 18, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 29, 2018 NWOS
NEW APPLICATION ENTERED
Dec 10, 2018 NWAP